The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.30
Ask: 9.50
Change: -0.35 (-3.59%)
Spread: 0.20 (2.151%)
Open: 9.55
High: 10.00
Low: 9.50
Prev. Close: 9.75
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Mon, 29th Mar 2021 15:13

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

F&C Investment Trust PLC - aims for long-term growth and income by investing in listed equities globally - Appoints Rain Newton-Smith as independent non-executive director, starting May 11. Newton-Smith will replace Roger Bone, who is retiring. She is chief economist at the Confederation of British Industry. Previous to the CBI, she was head of Emerging Markets at Oxford Economics. FTSE 250-listed F&C Investment Trust bills itself as the world's oldest collective investment scheme, having launched in 1868.

----------

Spirent Communications PLC - Crawley, England-based provider of testing, analytics and security for telecommunications networks - Appoints Maggie Buggie as non-executive director with effect on April 29. Buggie is currently chief business offer at SAP Services, which is part of Walldorf, Germany-based enterprise software developer SAP SE.

----------

Vesuvius PLC - London-based molten metal flow engineering - Hires Dinggui Gao as non-executive director, starting on Thursday. He currently is managing director of China for Formel D Group, a German service provider to the automotive and components supply industry.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery - Hires Karl Keegan as chief financial officer, effective immediately. Keegan was most recently chief executive officer of privately held Hox Therapeutics Ltd.

----------

Okyo Pharma Ltd - London-based biotechnology company focused on treatments of inflammatory dry eye diseases and ocular pain - Hires Rajkumar Patil as chief scientific officer. Says Patil has 30 years of ophthalmic and pharmaceutical research and development experience, including with Ora Inc and iVeena Delivery Systems. He also worked at the Alcon/Novartis Institute of Biomedical Research.

----------

Serinus Energy PLC - oil and gas exploration and production in Tunisia and Romania - Dawid Jakubowicz resigns immediately from board, while Eleanor Barke won't stand for re-election to the board at the May 13 annual general meeting. In their place, Serinus hires Natalie Fortescue and Jon Kempster. Fortescue was an investment banker at Investec and Oriel Securities. She joined Genel Energy PLC to establish the investor relations department and also worked with Premier Oil PLC on its reverse takeover by Chrysaor Energy Ltd. Kempster has held CFO positions at companies including London listings Frasers Group PLC and Wincanton PLC, and he currently is interim CFO of FireAngel Safety Technology Group PLC. Kempster also currently is a non-executive director of Bonhill Group PLC, Redcentric PLC and Ted Baker PLC.

----------

Fragrant Prosperity Holdings Ltd - seeking acquisition in cannabis therapeutics - Hires Daniel Reshef as non-executive director starting on Wednesday. Reshef has had a 25-year career in drug development, including with Hoffman La Roche, Genentech and Bristol Myers Squibb Co.

----------

French Connection Group PLC - London-based fashion retailer - Hires Neil Page as independent non-executive director. Page was CFO of retailer Carpetright PLC. French Connection entered a formal sales process at the beginning of month after receiving two separate takeover approaches.

----------

Braveheart Investment Group PLC - makes strategic investments in companies it thinks will outperform - Jonathan Freeman steps down as non-executive director "to devote more time to his other business interests". Starts process for finding a new non-executive director.

----------

Arix Bioscience PLC - venture capital investor in biotech companies - Pauses hire of James Noble and Axel Wieandt as non-executive directors, citing recently announced strategic review, which encompasses board composition.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.